iP Strategy

As innovation and commercialization become increasingly global and intellectual property rights are expanded to allow firms more nuance in protecting their inventions, we must focus on our core competence – producing radical new technologies which dramatically improve human health.

Two key elements of Chikujee’s commercialization environment are – the intellectual property strategy and established firm ownership over complementary assets (clinical trials and marketing channels.)

Chikujee strategy is to have formal intellectual property – in form of a well-defined patents &/or copyrighted source code – as the most effective mechanism to overcome the hazards associated with expropriation, particularly in the context of contracting negotiations.

Chikujee operates in environments characterized by complementary asset control by established biopharmaceutical companies alongside effective protection of the knowledge underlying our innovations. Our competitive advantage most likely lies not in integrating forward into established markets but developing a core competence at innovation – building an efficient and effective “Innovative Ecosystem.”

We feel that long-term competitive advantage for Chikujee Therapeutics may best be ensured by developing competencies at idea development alongside strategic cooperation with downstream commercialization partners.

At Chikujee we plan to build our competencies for an innovative ecosystem where advantage need not be at the expense of the advantage of established firms. In other words, our advantage derives not from the ability to disrupt established firms, but from the ability to offer a new and compelling value proposition for personalized health care as well as long term sustained growth.

contact

|

site map

|

careers

iP Strategy